Guided Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 561,000 compared to USD 369,000 a year ago. Net loss was USD 1.034 million compared to USD 6.749 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.57 a year ago. For the half year, operating loss was USD 1.440 million compared to USD 610,000 a year ago. Net loss was USD 1.694 million compared to USD 4.020 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.48 a year ago.